LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕
  • 28/02/2023

    How do we live in a bioeconomy? EuropaBio at the Swedish EU Council Presidency conference
  • 28/02/2023

    Helping Europe Deliver for Rare Disease Patients
  • 24/02/2023

    “Life is like a box of chocolates, you never know what you’ll get”
  • 23/02/2023

    EuropaBio Response to Public Consultation on Horizon Europe – interim evaluation
  • 17/02/2023

    Do your best and do not forget, there will always be a next time!
  • 17/02/2023

    Inter-association letter to raise our concern about the proposed definition of “natural polymers” in the REACH restriction of microplastics
  • 10/02/2023

    Leave no pathway unexplored
  • 06/02/2023

    Delivering Europe’s ambitions in rare disease
  • 01/02/2023

    Joint Statement: The Data Act is a leap into the unknown
  • 31/01/2023

    EuropaBio’s 2022 Patient BioForum sets out recommendations to address the challenges of patients with unmet medical needs and calls for multi-stakeholder approach
  • 17/01/2023

    EuropaBio launches SME BioForum in Rare Diseases
  • 17/01/2023

    EuropaBio launches Industry Advisory Group for new Biomanufacturing Platform
  • 16/01/2023

    SwiftPharma joins EuropaBio: pioneering sustainable, scalable and affordable plant-made therapeutic proteins
  • 19/12/2022

    EuropaBio sat down with new member Association of Biotechnological Companies Bioforum, to find out how they champion biotech in central and eastern Europe
  • 19/12/2022

    The Association of Biotechnological Companies Bioforum joins EuropaBio: representing Polish biotech at European legislative fora and involving Polish companies in the debate about the future of the industry
  • 13/12/2022

    EuropaBio Principles for Genetic Testing and Testing for Genetically-Driven Risk Factor
  • 13/12/2022

    EuropaBio sat down with new member SenseUp, to find out about the natural evolution approach for novel protein and RNA products
  • 13/12/2022

    SenseUp joins EuropaBio: leveraging the power of bio-tech for sustainable and commercially viable solutions
  • 08/12/2022

    ‘Rare Disease Moonshot’ – Scaling-up public-private partnerships to accelerate research into world’s rarest diseases
  • 02/12/2022

    EuropaBio’s 2022 Patient BioForum addresses the challenges of patients with unmet medical needs and calls for multi-stakeholder approach
Prev page
1234...16
Next page
EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.